Vanguard Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.4M Sell
6,988,183
-22,496
-0.3% -$108K ﹤0.01% 2117
2026
Q2
$33.7M Buy
7,010,679
+321,768
+5% +$1.41M ﹤0.01% 2148
2026
Q1
$30.1M Buy
+6,688,911
New +$29.2M ﹤0.01% 2123

Other funds holding ABUS

Vanguard Capital Management's ABUS Position: Q3 2026 in Review

Vanguard Capital Management reduced its Arbutus Biopharma (ABUS) stake by 0.32% in Q3 2026, selling an estimated $108K and leaving 6,988,183 shares worth $33.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Vanguard Capital Management first reported a position in ABUS in Q1 2026 and has held it in 3 quarters since. The position peaked at $33.7M in Q2 2026. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • Vanguard Capital Management held 6,988,183 shares of Arbutus Biopharma worth $33.4M as of Q3 2026.
  • Vanguard Capital Management sold 22,496 Arbutus Biopharma shares in Q3 2026, an estimated $108K.
  • Arbutus Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2117 holding.
  • Vanguard Capital Management first reported a position in Arbutus Biopharma in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Arbutus Biopharma position peaked at $33.7M in Q2 2026.
  • 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.